CDK6 and central nervous system cancer: miR-137 is a well-known suppressor of cell proliferation, mainly by regulating the cell cycle and enhancing differentiation of glioma stem cells via its downstream targets, such as Clcl12, Cox2, Pdgfr, Sp1, Tcf4 and/or Cdk6 [54].